88 series
Export
<<< of 5>>>
Accession Title Series type(s) Organism(s) Samples GDS Supplementary Contact Release date
Remove filtersFilter Remove filterPlatform: GPL16791 Remove filterBROADPEAK
GSE99669
The 8p11-p12 amplicon oncogene ASH2L regulates expression of genes involved in tumorigenic processes via promoter H3K4me3 in luminal breast cancer. (SUM-44 ASH2L knockdown H3K4me3 ChIP-seq)
12 Gary Hardiman May 24, 2024
GSE239481
Defining Cis-regulatory Elements and Transcription Factors that Control Human Cortical Interneuron Development
118 Kristen Kroll Apr 17, 2024
GSE241444
XIST directly regulates X-linked and autosomal genes in naïve human pluripotent cells
129 Kathrin Plath Dec 13, 2023
GSE248980
Chromatin context-dependent effects of epigenetic drugs on CRISPR-Cas9 editing
40 Ruben Schep Nov 30, 2023
GSE235745
Dynamic enhancer landscapes in human craniofacial development [human ChIP]
7 Laura E Cook Sep 11, 2023
GSE235858
Dynamic enhancer landscapes in human craniofacial development
67 Laura E Cook Sep 11, 2023
GSE241450
Pharmacologic inhibition of BAF chromatin remodeling complexes as a therapeutic approach to transcription factor-dependent cancers
119 Salih Topal Sep 11, 2023
GSE221046
Transposable elements as lineage-specific enhancers in endodermal-lineage cancers (ChIP-Seq)
7 Konsta Karttunen Aug 11, 2023
GSE221053
Transposable elements as lineage-specific enhancers in endodermal-lineage cancers
30 Konsta Karttunen Aug 11, 2023
GSE210220
Comprehensive analyses of partially methylated domains and differentially methylated regions in esophageal cancer reveal both cell-type- and cancer-specific epigenetic regulation
5 Yueyuan Zheng Aug 04, 2023
GSE210858
MAF functions as a pioneer transcription factor that initiates and sustains oncogenesis
49 Nikolaos Trasanidis Aug 01, 2023
GSE223834
Integrative genome-wide analysis of PBMCs confirmed SOD1-specific functionality of ATF3 in ALS blood
11
  • Download icon BROADPEAK
Karin M Danzer Jul 01, 2023
GSE227025
Causal linkage of presence of mutant NPM1 to efficacy of novel therapeutic agents against AML cells with mutant NPM1
10 Xiaoping Su Jun 14, 2023
GSE222571
Haploinsufficiency of NFKBIA reshapes the epigenome and imparts disease fate in diffuse gliomas
6 Lluis Espinosa Apr 28, 2023
GSE210277
Synthetic epigenetic reprogramming of mesenchymal to epithelial states using the CRISPR/dCas9 platform in triple negative breast cancer
45 Joe Cursons Apr 17, 2023
GSE182017
Pluripotency-Independent Induction of Human Trophoblast Stem Cells from Fibroblasts
114 Yosef Buganim Feb 21, 2023
GSE213533
FLI1 and FRA1 transcription factors drive the transcriptional regulatory networks characterizing muscle invasive bladder cancer
16 Serap Erkek Özhan Feb 20, 2023
GSE181829
Targeting Menin disrupts the KMT2A/B and polycomb balance to paradoxically activate bivalent genes
71 Mark Dawson Jan 13, 2023
GSE207401
DNA elements tether canonical Polycomb Repressive Complex 1 to human genes
32 Yuri Schwartz Jan 13, 2023
GSE181015
ERK signalling orchestrates neural differentiation by promoting the polycomb repressive complex.
47 Kate G Storey Sep 16, 2022